New Dosing Information
A New and Faster Way to Initiate Sotalol Therapy for Atrial Fibrillation (AFib) Patients
New Dosing Information
A New and Faster Way to Initiate Sotalol Therapy for Atrial Fibrillation (AFib) Patients
VIEW THE FULL PRESCRIBING INFORMATION
REQUEST MORE INFORMATION
WARNING: LIFE THREATENING PROARRHYTHMIA
Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation. To minimize the risk of drug induced arrhythmia, initiate or uptitrate intravenous sotalol in a facility that can provide continuous electrocardiographic monitoring and cardiac resuscitation [see Dosage and Administration (2.3) and Warnings and Precautions (5.1)].
Do not initiate intravenous sotalol therapy if the baseline QTc is longer than 450 ms. If the QTc prolongs to 500 ms or greater, reduce the dose or discontinue.
Resources Available To Learn More
The information contained on this site is intended for audiences in the United States only. The content on this site may not apply to non-US audiences as regulatory control, legal requirements, and/or medical practices my vary in other countries.
©2020 AltaThera Pharmaceuticals LLC. All Rights Reserved.
